Lumos Pharma Stock (NASDAQ: LUMO) stock price, news, charts, stock research, profile.
Open | $3.91 |
Close | - |
Volume / Avg. | 4.56K / 78.26K |
Day Range | $3.80 - $3.99 |
52 Wk Range | 1.37 - 4.55 |
Market Cap | $31.90M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 65 |
Short Interest | 5.39% |
Days to Cover | 1.28 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lumos Pharma (NASDAQ:LUMO) through any online brokerage.
Other companies in Lumos Pharma’s space includes: Fortress Biotech (NASDAQ:FBIO), Acurx Pharmaceuticals (NASDAQ:ACXP), Gain Therapeutics (NASDAQ:GANX), Curis (NASDAQ:CRIS) and Burning Rock Biotech (NASDAQ:BNR).
Lumos Pharma has a consensus price target of $14.50.
The stock price for Lumos Pharma (NASDAQ: LUMO) is $3.93 last updated September 23, 2024 at 11:58 AM EDT.
There are no upcoming dividends for Lumos Pharma.
Lumos Pharma’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Lumos Pharma.
Lumos Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.